Related Experiment Video
Updated: May 23, 2026

Efficient Generation of Murine Chimeric Antigen Receptor (CAR)-T Cells
Published on: February 2, 2024
Semisyngeneic hybrid resistance to murine teratocarcinoma cells
1McArdle Laboratory for Cancer Research, The University of Wisconsin. Madison, Wisconsin 53706, USA.
Abstract:
Resistance to two cultured lines of murine embryonal carcinoma was studied in F1 hybrids constructed between the tumor-syngeneic mouse strain 129/J and several allogeneic strains. Three of four such hybrid strains were significantly more resistant to the multipotent embryonal carcinoma line PCC3 than the tumor-syngeneic 129/J parent strain. All hybrid strains tested showed significantly higher resistance to the nullipotent embryonal carcinoma line F9 than the syngeneic strain. Hybrid resistance to embryonal carcinoma lines does not require a hybrid H-2 complex. Several kinds of evidence indicate that this hybrid resistance has an immunological basis.
Insights
Hybrid mice show increased resistance to embryonal carcinoma cell lines. This enhanced immunity, observed in F1 hybrids, suggests a significant immunological basis for tumor rejection, independent of the H-2 complex.
Area of Science:
- Immunology
- Developmental Biology
- Cancer Research
Background:
- Murine embryonal carcinoma (EC) cells are used as models for early development and cancer.
- Understanding resistance mechanisms to EC cells is crucial for cancer immunotherapy.
- Previous studies suggested genetic factors influence tumor rejection.
Purpose of the Study:
- To investigate the resistance of F1 hybrid mice to established murine embryonal carcinoma cell lines.
- To determine if hybrid resistance is dependent on the H-2 histocompatibility complex.
- To elucidate the immunological basis of hybrid resistance to EC cells.
Main Methods:
- Generation of F1 hybrid mice by crossing strain 129/J with allogeneic mouse strains.
- In vivo studies assessing tumor growth and resistance of hybrid mice against PCC3 (multipotent) and F9 (nullipotent) EC lines.
- Analysis of H-2 complex compatibility in resistant hybrid strains.
Main Results:
- Three out of four F1 hybrid strains exhibited significantly enhanced resistance to the PCC3 EC line compared to the 129/J parent strain.
- All tested F1 hybrid strains demonstrated significantly higher resistance to the F9 EC line than the syngeneic 129/J strain.
- Hybrid resistance was observed even in the absence of a hybrid H-2 complex.
Conclusions:
- F1 hybrid mice possess a potent, genetically controlled resistance to murine embryonal carcinoma cells.
- This hybrid resistance is mediated by immunological mechanisms and is not solely dependent on the H-2 histocompatibility complex.
- The findings provide insights into non-MHC-mediated tumor rejection mechanisms.

